Dapagliflozin shows promise in treating metabolic dysfunction-associated steatohepatitis (MASH), with or without type 2 diabetes in a new clinical trial conducted in China.
Master in Chemistry or Biochemistry or Pharmacy or Pharmaceutical Chemistry or Pharmacology or Bacteriology or Medicine or Microbiology or Biotechnology
Post graduate in Pharmacology or Regulatory science or a related field. experience in regulatory science, product development, clinical trials, or related fields.
PhD in Pharmaceutics, Pharmaceutical Sciences, Biotechnology, Molecular Biology or other relevant branches of Pharmacy and Science. OR First class master degree M.Pharm. M.S Pharm.. M. Tech. M. Sc in Pharmaceutics. Pharmaceutical Sciences, Biotechnology, Molecular Biology.
Masters degree diploma, life sciences, pharmacy, public health, healthcare or other related discipline with a minimum of 2 years of relevant clinical trial monitoring experience.
Candidates who are pursuing their Masters degree or equivalent course or candidates who have appeared for their qualifying Master’s degree examination and whose result is still awaited or candidates whose qualifying examinations have been delayed may also apply for this test.
The main aim of the scheme is to recognise active eminent senior resident Indian superannuated scientists for their outstanding contributions both nationally and internationally, in the area of Science, Technology, Engineering, Mathematics and Medicine, to promote excellence and growth in R&D.
M.Sc. in Biochemistry / Biotechnology from a recognized University. Research experience / knowledge of animal cell culture and gene cloning will be preferred.
1st class Post graduate Degree in Public Health, Epidemiology, Life Sciences, Biotechnology, Microbiology, Biochemistry, Pharmacology from a recognized university with 3 years experience.